multicenter automatic defibrillator implantation trial (MADIT)

Indications

• implantable cardiac defibrillators may improve survival in a selected patient population* at high risk for sudden death.

* Selection criteria:

• myocardial infarction
• left ventricular ejection fraction < 35%
• non-sustained ventricular tachycardia
• electrophysiologically-induced sustained monomorphic ventricular tachycardia not suppressed by procainamide

More general terms

• clinical trial

Additional terms

• implantable cardioverter defibrillator (ICD)